Orion Infusions (DHA:ORIONINFU) EV-to-EBITDA : 111.34 (As of May. 14, 2024)

Orion Infusions EV-to-EBITDA Chart

Orion Infusions Annual Data
	Trend	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23
EV-to-EBITDA		Get a 7-Day Free Trial					17.87	20.44	16.50	18.04	68.60

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial															55.62	68.60	66.22	70.63	-

Competitive Comparison of Orion Infusions's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Infusions's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Orion Infusions's EV-to-EBITDA falls into.

Orion Infusions EV-to-EBITDA Calculation

Orion Infusions's EV-to-EBITDA for today is calculated as:

Orion Infusions's current Enterprise Value is BDT12,423.5 Mil.
Orion Infusions's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT111.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Infusions  (DHA:ORIONINFU) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Orion Infusions's PE Ratio for today is calculated as:

Orion Infusions's share price for today is BDT596.50.
Orion Infusions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT2.095.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Orion Infusions EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Orion Infusions's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description